RPG Life SciencesNSE:RPGLIFE +0.09%93 Median PS Value is ₹1,048.08 as of Jun. 30, 2026, which is 100% below its 10-year median of 1.77. GuruFocus rates NSE:RPGLIFE with a GF Score™ of 93/100 and a GF Value™ of ₹2,359.83 (Fairly Valued). The stock has 3 warning signs investors should review. Among 544 Drug Manufacturers companies, RPG Life Sciences ranks worse than 92.83% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for RPG Life Sciences's Median PS Value or its related term are showing as below:
NSE:RPGLIFE'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 1.43 Med: 1.77 Max: 2.69
Current: 2.17
During the past 13 years, the highest Price to Median PS Value of RPG Life Sciences was 2.69. The lowest was 1.43. And the median was 1.77.
NSE:RPGLIFE's Price-to-Median-PS-Value is ranked worse than 92.83% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.84
vs NSE:RPGLIFE: 2.17
RPG Life Sciences (NSE:RPGLIFE) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
RPG Life Sciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2278.40
/
1,048.08
=
2.17
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences Median PS Value Related Terms
RPG Life Sciences Median PS Value Historical Data
* Premium members only.
The historical data trend for RPG Life Sciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:RPGLIFE vs ZTS, UTHR: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RPG Life Sciences Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where RPG Life Sciences's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 2.4499.
RPG Life Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹427.813.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RPG Life Sciences (NSE:RPGLIFE) has a Median PS Value of ₹1,048.08 as of Jun. 30, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RPG Life Sciences and its competitors. This is 59114% above median its historical median of 1.77. Over the past decade, RPG Life Sciences' Median PS Value has ranged from 1.43 to 2.69. According to the industry distribution chart, RPG Life Sciences ranks #505 out of 544 companies in the Drug Manufacturers industry, placing it in the top 92.8%.
Is RPG Life Sciences' Median PS Value too high?
RPG Life Sciences' current Median PS Value of ₹1,048.08 is 59114% above median its 10-year median of 1.77. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 2.69. Based on the distribution chart, RPG Life Sciences ranks #505 out of 544 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, RPG Life Sciences has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does RPG Life Sciences' Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, RPG Life Sciences ranks #505 out of 544 companies for Median PS Value. This places RPG Life Sciences in the lower half of its industry. The industry median Median PS Value is 0.84. Historically, RPG Life Sciences' own Median PS Value has ranged from 1.43 to 2.69 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.84, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on RPG Life Sciences and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RPG Life Sciences's current Median PS Value is ₹1,048.08, which is 59114% above median its own 10-year median of 1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RPG Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, RPG Life Sciences (NSE:RPGLIFE) is currently considered Fairly Valued. The stock's GF Value™ is ₹2,359.83, compared to a current price of ₹2,278.40 — trading 3.5% below its estimated fair value. The current Median PS Value is ₹1,048.08, which is 59114% above median its 10-year median of 1.77. RPG Life Sciences' overall GF Score™ is 93/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For RPG Life Sciences (NSE:RPGLIFE), the current Median PS Value is ₹1,048.08 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?
Based on GuruFocus' analysis, RPG Life Sciences stock appears to be undervalued.
The current stock price of ₹2,278.40 is trading 3.5% below its estimated GF Value™ of ₹2,359.83.
GuruFocus considers RPG Life Sciences to be Fairly Valued.
Key valuation signals for NSE:RPGLIFE:
Median PS Value: ₹1,048.08 (59114% above median its 10-year median of 1.77)
GF Value™: ₹2,359.83 vs. price of ₹2,278.40 (3.5% below fair value)
No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
93GF Score
Get the complete analysis for NSE:RPGLIFE
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:RPGLIFE has been successfully added to your 
